These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30225901)

  • 21. [Cardiac arrest in dialysis patients: Risk factors, preventive measures and management in 2015].
    Luque Y; Bataille A; Taldir G; Rondeau É; Ridel C
    Nephrol Ther; 2016 Feb; 12(1):6-17. PubMed ID: 26547563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results.
    Ayoub K; Fry E; Marji M; Masri A; Hesselson A; Ellison K
    Pacing Clin Electrophysiol; 2022 Jan; 45(1):124-131. PubMed ID: 34806769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arrhythmias and Sudden Cardiac Death in End Stage Renal Disease: Epidemiology, Risk Factors, and Management.
    Samanta R; Chan C; Chauhan VS
    Can J Cardiol; 2019 Sep; 35(9):1228-1240. PubMed ID: 31472819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation.
    Bogdan S; Nof E; Eisen A; Sela R; Rosenheck S; Freedberg N; Geist M; Ben-Zvi S; Haim M; Glikson M; Goldenberg I; Suleiman M;
    Am J Nephrol; 2015; 42(4):295-304. PubMed ID: 26529418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.
    Parekh RS; Meoni LA; Jaar BG; Sozio SM; Shafi T; Tomaselli GF; Lima JA; Tereshchenko LG; Estrella MM; Kao WH
    BMC Nephrol; 2015 Apr; 16():63. PubMed ID: 25903746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac arrest and sudden cardiac death on dialysis: Epidemiology, evaluation, treatment, and prevention.
    Alpert MA
    Hemodial Int; 2011 Oct; 15 Suppl 1():S22-9. PubMed ID: 22093597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist.
    Herzog CA
    Semin Nephrol; 2005 Nov; 25(6):363-6. PubMed ID: 16298256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends, Predictors and Outcomes After Utilization of Targeted Temperature Management in Cardiac Arrest Patients With Anoxic Brain Injury.
    Khan MZ; Khan MU; Patel K; Khan SU; Valavoor S; Osman M; Balla S; Munir MB
    Am J Med Sci; 2020 Oct; 360(4):363-371. PubMed ID: 32624168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable Defibrillator Therapy in Cardiac Arrest Survivors With a Reversible Cause.
    Ladejobi A; Pasupula DK; Adhikari S; Javed A; Durrani AF; Patil S; Qin D; Ahmad S; Munir MB; Rijal S; Wayne M; Adelstein E; Jain S; Saba S
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005940. PubMed ID: 29545361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis.
    Waks JW; Tereshchenko LG; Parekh RS
    J Electrocardiol; 2016; 49(6):848-854. PubMed ID: 27554424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends, Prevalence, and Outcomes of Sudden Cardiac Arrest Post Cardiac Transplant: A Nationwide 16-Year Study.
    Isath A; Rao SD; Siroky GP; Padmanabhan D; Bandyopadhyay D; Krittanawong C; Mohammed S; Chahal CAA; Perimbeti S; Mehta D; Contreras J
    Curr Probl Cardiol; 2022 Aug; 47(8):100901. PubMed ID: 34330560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients.
    Molnar MZ; Sumida K; Gaipov A; Potukuchi PK; Fülöp T; Joglekar K; Lu JL; Streja E; Kalantar-Zadeh K; Kovesdy CP
    Dement Geriatr Cogn Disord; 2017; 43(5-6):281-293. PubMed ID: 28448971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease: A nationwide population-based study.
    Liao HT; Lin MC; Tsai CY; Hsu CY; Wu TH
    J Chin Med Assoc; 2018 Sep; 81(9):766-771. PubMed ID: 30173723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac anxiety after sudden cardiac arrest: Severity, predictors and clinical implications.
    Rosman L; Whited A; Lampert R; Mosesso VN; Lawless C; Sears SF
    Int J Cardiol; 2015 Feb; 181():73-6. PubMed ID: 25482282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement.
    Krishnaswami A; Kiley ML; Anthony FF; Chen Y; Chen J; Rajagopal S; Liu TI; Young C; Paxton EW
    Perm J; 2016; 20(1):27-32. PubMed ID: 26562307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.
    Lee HF; See LC; Chan YH; Yeh YH; Wu LS; Liu JR; Tu HT; Wang CL; Kuo CT; Chang SH
    Intern Med J; 2018 Sep; 48(9):1123-1132. PubMed ID: 29808610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.